- Advocacy Documents Feb 10, 2017 Any Willing Pharmacy (AWP) Changes Are Needed to Improve Beneficiary Access to Specialty Pharmacies Overview of... read more
- New Report from the Centers for Medicare and Medicaid Services (CMS) Illustrates the Challenges Associated with Direct and Indirect Remuneration (DIR) Fees Jan 24, 2017 View Press Release The report validates the position of many industry experts that these fees,... read more
- NASP Issues Letter to CMS Jun 09, 2016 On March 4, NASP wrote a letter to CMS Deputy Administrator & Director Sean Cavanaugh regarding... read more
- NASP Comments to CMS on Part B Drug Proposal Jun 02, 2016 NASP comments on the organization’s concerns over the CMS proposed plan. Download PDF for details. read more
- NASP Summary of CMS Call Letter Apr 20, 2016 NASP provides a point-by-point summary of comments made on the 2017 CMS Call Letter and the... read more
- CMS Issues Final Call Letter Apr 06, 2015 On April 6, 2015 CMS issued the final payment rates and policy changes to Medicare Advantage... read more
- CMS Biosimilars Guidance Apr 02, 2015 Earlier this week the Centers for Medicare & Medicaid Services (CMS) issued four guidance documents detailing... read more
- NASP Responds to CMS Call Letter Mar 06, 2015 NASP responded to the CMS 2016 Call Letter with concerns about the impact of narrow network... read more
- NASP Meets with CMS Jan 20, 2015 NASP Board members and staff met with CMS staff on January 20 to discuss ways to... read more